Renin/Prorenin Receptor Antagonists (CCRP Therapeutics)

N/A

Report date: 2025/01/26 16:51:39
NME

Base Information

Drug NameRenin/Prorenin Receptor Antagonists (CCRP Therapeutics)
Drug Alias Namerenin/prorenin receptor antagonists (CCRP Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRenin inhibitors
TargetsRenin
Therapy Area/IndicationsHeart FailureDiabetic NephropathiesDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCCRP Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesCCRP Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsHeart FailureDiabetic NephropathiesDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A